Steven Cook Sells 17,950 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDAGet Free Report) CFO Steven Cook sold 17,950 shares of the business’s stock in a transaction on Monday, June 29th. The stock was sold at an average price of $21.07, for a total value of $378,206.50. Following the transaction, the chief financial officer directly owned 115,409 shares of the company’s stock, valued at $2,431,667.63. This trade represents a 13.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Omada Health Stock Up 3.1%

Shares of OMDA stock opened at $22.62 on Thursday. The business has a fifty day simple moving average of $17.00 and a 200 day simple moving average of $14.98. The company has a market cap of $1.34 billion and a P/E ratio of -83.78. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92.

Omada Health (NASDAQ:OMDAGet Free Report) last released its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The firm had revenue of $78.05 million for the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, equities research analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Omada Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Omada Health during the 4th quarter worth approximately $1,222,000. Divisadero Street Capital Management LP bought a new position in Omada Health during the third quarter worth $30,510,000. a16z Perennial Management L.P. acquired a new stake in Omada Health in the fourth quarter worth $2,480,000. Madryn Asset Management LP bought a new stake in Omada Health in the fourth quarter valued at $9,212,000. Finally, Parallel Advisors LLC raised its holdings in shares of Omada Health by 12,235.9% during the fourth quarter. Parallel Advisors LLC now owns 123,359 shares of the company’s stock valued at $1,947,000 after purchasing an additional 122,359 shares during the period.

Analysts Set New Price Targets

OMDA has been the subject of a number of research analyst reports. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, June 26th. Barclays boosted their target price on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday, May 8th. Canaccord Genuity Group set a $24.00 price target on Omada Health in a research note on Friday, May 8th. BMO Capital Markets cut their price objective on Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, March 6th. Finally, Citizens Jmp boosted their price objective on Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research report on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Omada Health currently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Get Our Latest Research Report on OMDA

About Omada Health

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

See Also

Insider Buying and Selling by Quarter for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.